Ziad  Ali, M.D., associate director of translational medicine, Columbia University Medical Center / New York-Presbyterian Hospital, explains recent advances in IVUS, OCT and FFR. This was a big topics discussed at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. Read the article “10 Reasons Why You Need Supplemental Imaging in the Cath Lab.”
 

Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford University Medical Center, explains balloon-based lithoplasty as a new alternative for treating heavily calcified coronary and peripheral vascular disease lesions.  The technology was among the new innovations at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. 

Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for both the ABSORB and SYNERGY stent trials, discussed the latest developments in bioresorbable stent technology. Bioresorbable stent technology was among the top innovations presented at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. Read the article "FDA Approves First Totally Bioresorbable Stent."

DAIC Editor Dave Fornell shares some of the most innovative new technologies shown on the expo floor and discusses in sessions at the Society of Cardiovascular Computed Tomography (SCCT) 2015 annual meeting.

Interview with Harold Litt, M.D, Ph.D., chief of cardiovascular imaging section and associate professor of radiology, University of Pennsylvania. He also served as co-principal investigator of the ACRIN-PA study of cardiac CT use in the ED. He also served as co-principal investigator of the ACRIN-PA study of cardiac CT use in the emergency department (ED). Litt spoke in sesveral sessions on how to begin using cardiac CT to evaluate chest pain to quickly rule in or rule out heart attacks.

Related ACRIN-PA Study Content:

VIDEO: CT for Chest Pain Evaluation in The Emergency Department — Interview with Harold Litt, M.D.

VIDEO: ACRIN-PA Trial Showed Benefit of CT in Assessing Chest Pain — Litt explaining the trial

Coronary CT Angiography is Effective to Evaluate Chest Pain Patients
 

Interview with Dee Dee Wang, M.D., FACC, FASE, advanced structural heart imaging staff cardiologist, Henry Ford Hospital, Detroit, about the use of 3-D printing to aid procedural planning and guidance in complex structural heart cases. Read the article “Henry Ford Hospital Study Shows 3-D Imaging Improves Fixing Broken Hearts.”     Read the article “The Future of 3-D Printing in Medicine.”
 

Interview at the American Society of Echocardiography (ASE) annual meeting with Federico Asch, M.D., M.D., FACC, FASE, associate director of the echocardiography core lab at Medstar Health Research Institute and assistant professor of medicine (cardiology) at Georgetown University.

Interview at the American Society of Echocardiography (ASE) annual meeting with Federico Asch, M.D., M.D., FACC, FASE, associate director of the echocardiography core lab at Medstar Health Research Institute and assistant professor of medicine (cardiology) at Georgetown University. He explains how ultrasound might have a roll in the future for breaking up clots and targeted delivery of gene and drug therapies.

Interview with Steve Goldstein, M.D., director, noninvasive lab, Medstar Washington Heart Institute, Washington, D.C., on the uses of echo guidance for interventional procedures in the cath lab. He spoke with DAIC Editor Dave Fornell at ASE 2015.

Interview with Ted Feldman, M.D., FACC, MSCAI, FESC, cardiac cath lab director, Evanston Hospital, North Shore Health System, and principle investigator, Everest II MitraClip U.S. pivotal trial, at the Transcatheter Valve Therapies 2015 meeting. Watch the VIDEO “Advances and Future Directions for Transcatheter Valves.”

Treating Mitral Regurgitation in High Risk PatientsUsing the MitraClip — article by Allen Atchley, M.D.
 

Interview with Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's Skirball Center for Innovation, at the Transcatheter Valve Therapies 2015 meeting. Read the article "Transcatheter Mitral Valve Replacement Devices in Development."
 

Interview with Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's Skirball Center for Innovation, at the Transcatheter Valve Therapies 2015 meeting. Read the article "Transcatheter Mitral Valve Replacement Devices in Development," and the article "Advances and Future Directions for Transcatheter Valves."
 

The Centers for Medicare and Medicaid (CMS) has issue a draft list Stage 3 Meaningful Use requirements. Jeff Coughlin, senior director, federal and state affairs, Health Information and Management Systems Society (HIMSS), explains what these requirements include at the HIMSS 2015 annual meeting.

During HIMSS 2015, Louis Lannum, director, ITD enterprise imaging, information technology division, Cleveland Clinic, explained in sessions how to create an enterprise imaging system that goes beyond PACS to service all imaging and data needs of departments in the hospital enterprise.

In 2015, the FDA approved the first two drug-coated balloons for the U.S. market to treat peripheral artery disease in the SFA. Doug Drachman, M.D., Mass General Hospital, who served a the site principal investigator for the Lutonix balloon trial, explains his experiences and insights with these devices in an interview at ACC 2015. Read the article “Drug-eluting Balloons Enter the U.S. Market.”
 

Learn about the trends and new technology in electrophysiology (EP) in an interview with David Wilber, M.D., editor of JACC's Clinical EP, and medical director, clinical electrophysiology, director, Cardiovascular Institute, co-director, Cardiovascular Research Institute, Loyola University Medical Center, Chicago.

Several late-breaking trials for transcatheter aortic valve replacement (TAVR) were presented at the American College of Cardiology (ACC) 2015. Find out some of the insights to that data with Ajay Kirtane, M.D., SM, chief academic officer and director of the interventional cardiology fellowship program, Columbia University Medical Center / New York-Presbyterian Hospital, and CRF/TCT faculty.

Sentara Health in Virginia is going through the process of choosing a new cardiovascular information system (CVIS) and implementing enterprise imaging. Sentara's IT leader shares information on what elements they are looking for and how they plan to wire their system to achieve a new level of interoperability for cardiology. They were at RSNA 2014 visiting with CVIS vendors as part of their selection process. Read the article "10 Questions to Ask When Purchasing a Cardiovascular Information System."
 

QICS is a unique, automated workflow management solution to help today's medical professionals enhance the delivery of care, reduce risks, optimize user productivity and meet regulatory requirements compliance. QICS can provide workflow efficiencies that help providers improve performance and satisfaction for both physicians and patients. Qualitative Intelligence and Communication System (QICS) solutions can help: Create records for accountability and analytics — Meet regulatory requirements — Reduce manual processes to streamline workflow — Optimize communication to help deliver better care

Here are ITN Editor Dave Fornell's choices for the most innovative new imaging technologies shown on the expo floor at the Radiological Society of North America (RSNA) 2014 annual meeting.